Image For Activity Cover
Biosimilars: A collaboration between ASGE, SGNA and France Foundation
Released: April 2018
About this Webinar
This learning activity contains 2 recorded webinars created in partnership by ASGE, SGNA, and The France Foundation. This activity is supported by an educational grant from Pfizer, Inc.  All planning, implementing, evaluating and recording keeping of this activity was the sole responsibility of the provider with no influence by the commercial entity.

Fundamentals of Biosimilars in the GI Clinic
Hear 3 perspectives from the interdisciplinary team. Kenneth McQuaid, MD, FASGE discusses when to prescribe biosimilars, Cathleen Shellnutt, MSN, RN, CGRN discusses how to administer biosimilars, and Edward Li, PharmD, explains the safety and efficacy of biosimilars.

Biosimilars & Patients with Inflammatory Bowel Disease
Test your skills in 3 cases commonly seen in the GI clinic presented by Catherine Bauer, MSN, RN, CGRN. Kenneth McQuaid, MD, FASGE answers common questions about when to prescribe and when to switch patients to a biosimilar. Edward Li, PharmD, compares the efficacy of biosimilars to their reference drugs.
Learning Objectives
By completing this learning activity, you will be able to:
  • Define biosimilars, extrapolation, and interchangeability on the basis of FDA definitions and guidance
  • Explain the basics of the FDA approval process and how it uses the “totality of evidence” to determine biosimilarity
  • Explore data on safety and immunogenicity of originator biologics and biosimilars
  • Examine relevant regulations concerning pharmacy substitution with biosimilars
  • Discuss the role of the nurse in the process of biosimilar use
  • Review key concepts in patient teaching related to biosimilarsApply the foundational knowledge on biosimilars into clinical situations relevant to gastroenterology practice
  • Discuss the role of the nurse in the process of biosimilar use
  • Review key concepts in patient teaching related to biosimilars
Access the Biosimilar Webinars
Access these 2 Biosimilar webinars here. A PDF version of the slide presentation can be found on the Course tab of this activity.
Disclosures and Faculty
In accordance with the ACCME Standards for Commercial Support, ASGE, SGNA, and The France Foundation (TFF) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. ASGE, SGNA and TFF resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, ASGE, SGNA and TFF seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. ASGE, SGNA and TFF are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Activity Staff Disclosures
The planners, reviewers, editors, staff, CME/CE committee, or other members at ASGE, SGNA and TFF who control content have no relevant financial relationships to disclose.

Faculty Disclosure
The following faculty report that they have no relevant financial relationships to disclose:

Kenneth McQuaid, MD
Cathleen Shellnutt, MSN, RN
Catherine Bauer, MSN, RN

The following faculty report that they have relevant financial relationships to disclose:

Edward Li, PharmD, serves as a consultant for Pfizer, Inc. He has received honoraria from Hospira/Pfizer.

ASGE, SGNA and TFF require CME/CE faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. ASGE, SGNA and TFF do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
Continuing Medical Education
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American Society for Gastrointestinal Endoscopy (ASGE), the Society of Gastroenterology Nurses and Associates, (SGNA), Inc., and The France Foundation (TFF). The American Society for Gastrointestinal Endoscopy (ASGE) is accredited by the American Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The ASGE designates this internet activity enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.
Instructions on how to claim CE/CME can be found on The France Foundation website upon completion.
Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered
Android App Download IOS App Download Powered By